Abstract TP156: The Stereotactic Intracerebral Hemorrhage Underwater Blood Aspiration (SCUBA) Technique for Minimally Invasive Endoscopic Intracerebral Hemorrhage Evacuation: A Pilot Study

Yan Hou,Ya-Huei Li,Sherif Elsayed,Samantha Casciani,Inam U Kureshi
DOI: https://doi.org/10.1161/str.55.suppl_1.tp156
IF: 10.17
2024-02-01
Stroke
Abstract:Introduction: Spontaneous intracerebral hemorrhages (ICH) remains the most devastating form of stroke. Only approximately 20% survivors achieve functional independence at six months after ICH. Up to today, there are no medical or surgical treatments with proven functional benefits for this population. The Stereotactic ICH Underwater Blood Aspiration (SCUBA) allows minimally invasive endoscopic hematoma evacuation in basal ganglia. In this pilot study, we tested that early hematoma evacuation by SCUBA may improve functional outcome. Methods: The Study included 10 ICH patients (age 18-85 years, pre-morbid mRS 0-1, hematoma volume 30-90ml) who underwent SCUBA from 2019 to 2022. SCUBA patient was matched with control ICH patient who received standard medical treatment at 1:1 ratio by variables (hematoma volume and laterality, intraventricular hemorrhage [IVH] with hydrocephalus, age, NIHSS, GCS). The comparison between SCUBA and Controls were carried out by T-test, Mann-Whitney U Test or Fisher's Exact Test as appropriate. Results: Of the 10-paired SCUBA patients and controls, the mean age was 66 years, 45.0% were females, pre-op median NIHSS of 18, 45.0% were intubated, and 30.0% had IVH with hydrocephalus and EVD placed. Among SCUBA patients, the median hematoma volume is 34.0 ml; 90.0% of hematoma was located in basal ganglia. The median time from the last known well to SCUBA initiation was 22.3 hours. Hematoma volume reduction by 80% was achieved in 70.0% of SCUBA patients and 100.0% patients with residual hematoma volume less than 15 ml. SCUBA patients had shorter median NeuroICU stay than controls (SCUBA 5 vs. Control 11 days, p=0.029). SCUBA patients tended to have lower hospital mortality rate (SCUBA 10% vs. Control 20%), and a higher proportion of SCUBA patients were discharged to acute rehab (SCUBA 50% vs. Control 10%). At three months of follow-up, none of the patients were functionally independent, but more SCUBA patients achieved mRS 3 (SCUBA 37.5% vs. Control 16.7%). Conclusions: Our pilot study suggests that early SCUBA can efficiently evacuate deep hematoma with potential of improving functional outcome. Further study requires more patients and longer follow-up.
peripheral vascular disease,clinical neurology
What problem does this paper attempt to address?